<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Isolated <z:e sem="disease" ids="C0271355" disease_type="Disease or Syndrome" abbrv="">abducens nerve palsy</z:e> is a rare complication of treatment with various drugs </plain></SENT>
<SENT sid="1" pm="."><plain>Here, the authors report the case of a 23-year-old female with isolated left <z:e sem="disease" ids="C0271355" disease_type="Disease or Syndrome" abbrv="">abducens nerve palsy</z:e> after long-term <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>The association is based on the temporal relationship and the exclusion of other possible etiologic factors following extensive laboratory and imaging diagnostics </plain></SENT>
<SENT sid="3" pm="."><plain>The authors suggest that isolated <z:e sem="disease" ids="C0271355" disease_type="Disease or Syndrome" abbrv="">abducens nerve palsy</z:e> may be a presenting sign of a toxic <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> associated with <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> therapy </plain></SENT>
<SENT sid="4" pm="."><plain>After the exclusion of other organic lesions, especially idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, and an assessment of the risk-benefit ratio, discontinuation of treatment must be considered in such cases </plain></SENT>
</text></document>